A biology-driven approach identifies the hypoxia gene signature as a predictor of the outcome of neuroblastoma patients

Keyphrases

• Neuroblastoma 100%
• Driven Approach 100%
• Hypo 100%
• Hypoxia Signature 100%
• Hypoxia 83%
• Tumor 33%
• Poor Prognosis 33%
• Risk Factors 16%
• Neuroblastoma Cell Line 16%
• MYCN Amplification 16%
• Poor Outcome 16%
• Gene Expression 16%
• Neuroblastoma Tumor 16%
• Risk Stratification 16%
• Human Cancer 16%
• Tumor Microenvironment 16%
• Gene Expression Profile 16%
• Patient Outcomes 16%
• Good Prognosis 16%
• Discriminatory Power 16%
• Differential Gene Expression 16%
• Multivariate Cox Analysis 16%
• Independent Prognostic Factor 16%
• Aggressiveness 16%
• Tumor Outcome 16%
• MYCN Oncogene 16%
• K-means 16%
• L1-L2 16%
• Feature Selection Methods 16%
• Low Oxygen 16%

Biochemistry, Genetics and Molecular Biology

• Feature Extraction 50%

Medicine and Dentistry

• Feature Extraction 14%